Design Strategies for and Stability of mRNA–Lipid Nanoparticle COVID-19 Vaccines

Messenger RNA (mRNA) vaccines have shown great preventive potential in response to the novel coronavirus (COVID-19) pandemic. The lipid nanoparticle (LNP), as a non-viral vector with good safety and potency factors, is applied to mRNA delivery in the clinic. Among the recently FDA-approved SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting, Tian, Yang, Zheng, Aiping, Cui, Chunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572882/
https://www.ncbi.nlm.nih.gov/pubmed/36236141
http://dx.doi.org/10.3390/polym14194195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572882/
https://www.ncbi.nlm.nih.gov/pubmed/36236141
http://dx.doi.org/10.3390/polym14194195

Ejemplares similares